Philippe Beuzeboc

12.9k citations
243 papers · 7.7k · 4 hit papers · h-index 47

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Bone health and treatments
    • Cancer Treatment and Pharmacology

Papers in

    • Prostate Cancer Treatment and Research 73
    • Prostate Cancer Diagnosis and Treatment 30
    • Cancer Treatment and Pharmacology 36
    • HER2/EGFR in Cancer Research 15
    • Cancer Immunotherapy and Biomarkers 13

Philippe Beuzeboc

229 papers receiving 7.5k citations

Philippe Beuzeboc's Hit Papers

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes 2024 · 45 citations
450+4+9Years since publication100200300400

Peers

Philippe Beuzeboc
Comparison fields: 5 of 117
  • Cancer Research 1.9k
  • Oncology 2.9k
  • Pulmonary and Respiratory Medicine 2.7k
  • Radiology, Nuclear Medicine and Imaging 921
  • Pathology and Forensic Medicine 626
Replace Frédéric Rolland with:
Frédéric Rolland France
Mikhail Lichinitser Russia
Lee S. Rosen United States
Maciej Krzakowski Poland
Sergio Bracarda Italy
Gilberto de Castro Brazil
Shunji Takahashi Japan
Clara C. Chen United States
Daniel Castellano Spain
Roger von Moos Switzerland
Philippe Beuzeboc relative to Frédéric Rolland France Frédéric Rolland's profile →
Citations per field
00.5×1.5×2.4×
Frédéric Rolland · 1×
Citations per year

Countries citing papers authored by Philippe Beuzeboc

Since Specialization
Citations

This map shows the geographic impact of Philippe Beuzeboc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Beuzeboc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Beuzeboc more than expected).

Fields of papers citing papers by Philippe Beuzeboc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Beuzeboc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Beuzeboc. The network helps show where Philippe Beuzeboc may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Beuzeboc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Beuzeboc Line = papers co-authored together Philippe Beuzeboc links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Hit paper breakdown →
2012428
2
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Hit paper breakdown →
2021365
3 2007341
4 1994337
5 1996330
6
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015325
7 2003265
8 2009173
9 2009172
10 2008138
11 1989134
12 2014134
13 1995133
14 2009123
15 2001121
16 1996115
17 2011111
18 1996107
19 1999106
20 2005105

About Philippe Beuzeboc

Philippe Beuzeboc is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 243 papers that have together received 7.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (73 papers), Cancer Treatment and Pharmacology (36 papers), Bladder and Urothelial Cancer Treatments (35 papers), Prostate Cancer Diagnosis and Treatment (30 papers), Breast Cancer Treatment Studies (27 papers), Radiopharmaceutical Chemistry and Applications (20 papers), HER2/EGFR in Cancer Research (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.9k citations), Pulmonary and Respiratory Medicine (2.7k citations), Radiology, Nuclear Medicine and Imaging (921 citations) and Pathology and Forensic Medicine (626 citations). Philippe Beuzeboc has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include P Pouillart, Stéphane Oudard, Thierry Dorval, Bernard Asselain, Suzy Scholl, Karim Fizazi, M Jouve, Jean‐Yves Pierga, T Palangié and Anne Vincent‐Salomon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact